Hybrid Cardiac Rehabilitation Trial

NACompletedINTERVENTIONAL
Enrollment

186

Participants

Timeline

Start Date

May 6, 2019

Primary Completion Date

April 5, 2021

Study Completion Date

May 30, 2022

Conditions
Coronary Artery DiseaseAcute Coronary Syndrome
Interventions
OTHER

Comprehensive assessment

Includes evaluation about physical activity, diet, tobacco consumption, overweight/obesity, blood pressure, self-efficacy, and medications. Additionally, levels of lipids and glycaemia will be reviewed from clinical chart.

OTHER

Counseling

Physical activity, diet, smoking, and medication compliance counseling will be provided by the physiotherapist across exercise sessions, using a self-efficacy approach. A booklet was designed in order to support the individual counseling.

OTHER

Group education

Group education sessions about physical activity, diet, smoking, and medication compliance (without individual counseling), as actually performed in each center.

OTHER

Exercise sessions in hybrid program

"10 supervised exercise sessions over 4-6 weeks of aerobic and resistance training will ensue, supervised by a physiotherapist. Exercise sessions are 10 minutes in duration at the beginning of the program, and are progressed to 60 minutes by the end as tolerated.~Intensity of exercise will be moderate."

OTHER

Exercise sessions in standard program

"18-22 supervised exercise sessions are delivered over the 8-12 week program. These sessions include aerobic and resistance training and a similar progression of duration as the experimental group.~Intensity of exercise will be moderate."

OTHER

Transition to unsupervised phase

After 4-6 weeks with face-to-face exercise sessions in hybrid program, all patients will be monitored through mobile technology. Delivery methods will include voice calls biweekly, and text messaging three per week through to 10-12 weeks from program initiation. The content will promote physical activity, healthy diet, and medication adherence.

Trial Locations (6)

4781176

Universidad de La Frontera, Temuco

Unknown

Hospital Regional de Antofagasta, Antofagasta

Complejo Hospitalario San José, Santiago

Hospital Clínico Universidad de Chile, Santiago

Hospital San Borja Arriarán, Santiago

Hospital San Juan de Dios, Santiago

All Listed Sponsors
lead

Universidad de La Frontera

OTHER

NCT03881150 - Hybrid Cardiac Rehabilitation Trial | Biotech Hunter | Biotech Hunter